Souhaitez-vous accéder aux communiqués récents ?

Rinzimetostat 400 mg once daily selected as RP3D in combination with darolutamide for Himalayas-1 global Phase 3 registrational trial in post-abiraterone mCRPC, with initiation expected in 1H 2026 At...

Exceeds All Financial Guidance MetricsACV as of January 31, 2026, $602.4M, up 17% Year-Over-YearFiscal 2026 ACV Net Retention Rate of 112%Announces $100M Accelerated Share Repurchase Program ...

New York, NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- On a night that brought together the worlds of Broadway, fashion, media, and society, Capitale once again proved why it remains one of New York...

Celebration, FL, March 31, 2026 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a real estate and PropTech enterprise, today announced that it has added over...

National Canadian Film Day returns on April 15 with more international screenings than ever before

Landmark regulatory milestone makes the River stent available for adults with severe IIH – a debilitating, historically undertreated condition – who have failed medical therapy Serenity Medical...

RapidDirect DFM 4.0 eliminates design friction via real-time AI. Features 4x better feature recognition and online thread annotation to accelerate sourcing

PolyPid Submits First Modules as Part of Rolling NDA Review; Completion expected in Second Quarter of 2026  U.S. Commercialization Partnership Negotiations on Track PETACH TIKVA, Israel, March 31,...

Celebration, FL, March 31, 2026 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a real estate and PropTech enterprise, today announced that it has added over...

IMNN-001 is the first frontline immunotherapy to demonstrate the potential for a clinically meaningful overall survival benefit in women newly diagnosed with advanced ovarian cancer Final Phase 2...